Biosimilar
Variant of a biopharmaceutical
📊 Rating
1 news mentions · 👍 0 likes · 👎 0 dislikes
📌 Topics
- Pharmaceuticals (1)
- Economy (1)
- Finance (1)
🏷️ Keywords
Merck (1) · Keytruda (1) · Patent expiration (1) · Sales forecast (1) · Biosimilars (1) · Pharma news (1) · Wall Street (1)
📖 Key Information
A biosimilar (also known as follow-on biologic or subsequent entry biologic) is a biologic medical product that is almost an identical copy of an original product that is manufactured by a different company. Biosimilars are officially approved versions of original "innovator" products and can be manufactured when the original product's patent expires. Reference to the innovator product is an integral component of the approval.
📰 Related News (1)
🔗 Entity Intersection Graph
People and organizations frequently mentioned alongside Biosimilar:
- 🌐 Term of patent (1 shared articles)
- 🌐 Pembrolizumab (1 shared articles)
- 🌐 Merck (1 shared articles)